Figure 3.
Pooled and individual estimates of relative risk (RR) and 95% CIs of the secondary outcome cardiovascular mortality for different therapies. Data are shown stratified by individual class blockers (beta-blockers, ACE inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists and other drug classes). Random-effects model used.